Abstract
The current COVID-19 pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected the large population across the globe by serious respiratory illness and death. Since the medicine for this new disease is yet to discover, the treatment options against pandemic COVID-19 are very limited and unsatisfactory. Further, the hospitals, wherethe COVID-19 patients are admitted for treatment, are the major source of the spread of this virus, as it survives on the surfaces of inanimate objects for days. Therefore, hospitals have become hotspots for SARS-CoV-2 infection. The non-availability of quality personal protective equipment (PPE) and exposure to severe COVID patients have been major factors for the infection in millions of healthcare workers. However, developing an effective medicine has remained challenging due to its unpredictable mutation rate. Here, this article describes functionalized photocatalytic nanocoatings to destroy the COVID-19 virus, which can be applied on the surface of inanimate objects, such as paper, cloth, glass, wood, ceramic, metallic, and polymeric surfaces. With the supporting experimental results, various possible ways of killing the virus and its relevant mechanism are discussed. This article provides new insights for developing nano solutions to address this COVID-19 issue.
Keywords: COVID-19, SARS-CoV-2, hospital infection, surface coatings, nano coatings, photocatalyst.
Coronaviruses
Title:Functionalized Photocatalytic Nanocoatings for Inactivating COVID-19 Virus Residing on Surfaces of Public and Healthcare Facilities
Volume: 2 Issue: 12
Author(s): Manjunatha Channegowda *
Affiliation:
- Department of Chemistry, RV College of Engineering, Bengaluru-560059,India
Keywords: COVID-19, SARS-CoV-2, hospital infection, surface coatings, nano coatings, photocatalyst.
Abstract: The current COVID-19 pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected the large population across the globe by serious respiratory illness and death. Since the medicine for this new disease is yet to discover, the treatment options against pandemic COVID-19 are very limited and unsatisfactory. Further, the hospitals, wherethe COVID-19 patients are admitted for treatment, are the major source of the spread of this virus, as it survives on the surfaces of inanimate objects for days. Therefore, hospitals have become hotspots for SARS-CoV-2 infection. The non-availability of quality personal protective equipment (PPE) and exposure to severe COVID patients have been major factors for the infection in millions of healthcare workers. However, developing an effective medicine has remained challenging due to its unpredictable mutation rate. Here, this article describes functionalized photocatalytic nanocoatings to destroy the COVID-19 virus, which can be applied on the surface of inanimate objects, such as paper, cloth, glass, wood, ceramic, metallic, and polymeric surfaces. With the supporting experimental results, various possible ways of killing the virus and its relevant mechanism are discussed. This article provides new insights for developing nano solutions to address this COVID-19 issue.
Export Options
About this article
Cite this article as:
Channegowda Manjunatha *, Functionalized Photocatalytic Nanocoatings for Inactivating COVID-19 Virus Residing on Surfaces of Public and Healthcare Facilities, Coronaviruses 2021; 2 (12) : e070921191640 . https://dx.doi.org/10.2174/2666796702666210222110403
DOI https://dx.doi.org/10.2174/2666796702666210222110403 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Structure-Based Quantitative Structure Activity Relationship Analysis of Omuralide Analogs in the 20S Proteasome: A Covalent Inhibitor COMBINE Study
Letters in Drug Design & Discovery Medicinal Chemistry of Selective Neurokinin-1 Antagonists
Current Topics in Medicinal Chemistry Advances in Parallel Screening of Drug Candidates
Current Medicinal Chemistry QT Interval Monitoring and Drugs Management During COVID-19 Pandemic
Current Reviews in Clinical and Experimental Pharmacology 3D-QSAR Study on a Series of Bcl-2 Protein Inhibitors Using Comparative Molecular Field Analysis
Protein & Peptide Letters Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development
Current Topics in Medicinal Chemistry Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors
Current Drug Targets Multicomponent 1,3-Dipolar Cycloaddition Reactions in the Construction of Hybrid Spiroheterocycles
Current Organic Chemistry <i>In Silico</i> Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of <i>Nigella Sativa</i>
Current Drug Discovery Technologies Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Meet the Editorial Board Member
CNS & Neurological Disorders - Drug Targets Antiproliferative and Antifungal Activities of 1,3-diarylpropane-1,3-diones Commonly used as Sunscreen Agents
Letters in Drug Design & Discovery Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
Current Drug Targets Bio-Basis Function Neural Networks in Protein Data Mining
Current Pharmaceutical Design New Ligands of the Tubulin Colchicine Site Based on X-Ray Structures
Current Topics in Medicinal Chemistry Cell Cycle Molecular Targets in Novel Anticancer Drug Discovery
Current Pharmaceutical Design Selenium Status in Elderly People: Longevity and Age-Related Diseases
Current Pharmaceutical Design Meta-analysis of Lung Cancer Patients in COVID-19
Current Respiratory Medicine Reviews Recent Developments in the Medicinal Chemistry of NK2 Receptor Antagonists
Current Topics in Medicinal Chemistry Amniotic Fluid Embolism: Review
Current Pharmaceutical Biotechnology